Post Resch Tallon Group’s Bristol-Myers Squibb BMY Stock Holding History

Post Resch Tallon Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$353K	Sell	6,119 -165	-3%	-$9.47K	0.24%	73
2026 Q1	$388K	Buy	6,284 +239	+4%	+$13.9K	0.31%	58
2025 Q4	$326K	Buy	6,045 +379	+7%	+$18.2K	0.28%	66
2025 Q3	$256K	Buy	+5,666	New	+$265K	0.23%	80
2025 Q2	–	Sell	-3,466	Closed	-$206K	–	101
2025 Q1	$206K	Buy	+3,466	New	+$202K	0.21%	86

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Post Resch Tallon Group's BMY Position: Q2 2026 in Review

Post Resch Tallon Group reduced its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2026, selling an estimated $9.47K and leaving 6,119 shares worth $353K. The position accounts for 0.24% of the portfolio, ranked #73.

Post Resch Tallon Group first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $388K in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Post Resch Tallon Group held 6,119 shares of Bristol-Myers Squibb worth $353K as of Q2 2026.
Post Resch Tallon Group sold 165 Bristol-Myers Squibb shares in Q2 2026, an estimated $9.47K.
Bristol-Myers Squibb made up 0.24% of Post Resch Tallon Group's portfolio in Q2 2026, its #73 holding.
Post Resch Tallon Group first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
Post Resch Tallon Group's Bristol-Myers Squibb position peaked at $388K in Q1 2026.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.